Increasing prevalence of various types of cancers across the globe, growing geriatric population, and rising investments in developing novel therapeutics are some key factors expected to drive global market growth.
Increasing prevalence of various types of cancers across the globe, growing geriatric population, and rising investments in developing novel therapeutics are some key factors expected to drive global market growth
According to Emergen Research, the global antibody-drug conjugates market size was USD 3.18 billion in 2020 and is expected to reach USD 20.01 billion in 2028 and register a robust revenue CAGR of 25.8% during the forecast period, 2021-2028.
Market Dynamics:
Antibody-drug Conjugates (ADCs) are highly potent biopharmaceutical drugs built by attaching a small molecular therapeutic agent or anticancer drug to an antibody with permanent or labile linker. ADCs target to deliver chemotherapy agents to the cancer cells without harming healthy cells and help in faster patient recovery. Factors such as increasing research activities on antibody therapies, availability of funds to accelerate ongoing research on drug discovery and oncology diseases, and rising healthcare spending are expected to fuel global market revenue growth during the forecast period. In addition, rising number of biotechnology and pharmaceutical companies along with research centers, and increasing FDA drug approvals and preclinical research activities are other factors expected to fuel market growth between 2021 and 2028.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/754
However, high costs associated with antibody-drug conjugates, stringent regulatory norms, and inaccessibility to advanced therapies due to lack of funds, especially in developing countries are some key factors expected to limit the adoption of antibody-drug conjugates and hamper market revenue growth to a certain extent during the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Breast Cancer Segment To Account for Largest Revenue Share:
The breast cancer segment is expected to account for largest revenue share over the forecast period. Increasing prevalence of breast cancer across the globe, growing demand for advanced drugs and therapies, rising number of product approvals for breast cancer treatment, and increasing awareness about early diagnosis and treatment are some key factors expected to drive revenue growth of the segment during the forecast period.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/754
Hospital Segment to Register Rapid Revenue CAGR:
The hospital segment revenue is expected to expand at a robust CAGR between 2021 and 2028. This can be attributed to factors such as large patient pool, increasing hospital admissions, rapid adoption of advanced drugs and therapies for various types of cancers, and rising number of hospitals offering cancer treatment.
North America To Lead In Terms of Revenue Share:
North America is expected to dominate other regional markets in terms of revenue share over the forecast period owing to increasing prevalence of breast cancer, blood cancer, brain tumor, ovarian cancer, and lung cancer across the region, presence of well-developed healthcare infrastructure and research facilities, and rapid technological advancements. In addition, increasing awareness about early diagnosis and treatment, presence of leading market players, rising product launches, and increasing R&D activities for developing advanced products are expected to fuel market growth in North America.
Major Companies in the Market Include:
- Oxford BioTherapeutics
- Bayer AG
- Immunomedics Inc.
- Concortis Biotherapeutics
- F. Hoffman-La Roche Ltd.
- Pfizer Inc.
- ImmunoGen Inc.
- AbbVie Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/antibody-drug-conjugates-market
For the purpose of this report, Emergen Research has segmented the global antibody drug conjugates market on the basis of technology, application, end use, and region:
Technology Outlook (Revenue, USD Billion; 2018–2028)
- Cleavable Linker
- Non-Cleavable Linker
Application Outlook (Revenue, USD Billion; 2018–2028)
- Blood Cancer
- Leukemia
- Lymphoma
- Brain Tumor
- Ovarian Cancer
- Breast Cancer
- Lung Cancer
- Others
End Use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals
- Research Institute
- Clinics
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Insights into our Other Published Healthcare Reports:
Cardiac Monitoring & Cardiac Rhythm Management Devices Market To Be Worth USD 29.32 Billion by 2027 | Emergen Research
Neurostimulation Devices Market To Reach USD 13.70 Billion by 2027 Growing at a CAGR of 12.6% | Emergen Research
Industrial Microbiology Market To Be Worth USD 17.71 Billion by 2027| Emergen Research
Surgical Instrument Tracking Systems Market To Reach USD 431.6 Million by 2027| Emergen Research
Medical Lighting Technologies Market Size To Be Worth USD 2.99 Billion by 2027 | Emergen Research
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Our Press release@ https://www.emergenresearch.com/press-release/global-antibody-drug-conjugates-market